Complete genome sequence of Nocardia brasiliensis HUJEG-1

Journal of Bacteriology

Volumn 194, Issue 10, 2012, Pages 2761-2762

  Vera Cabrera, Lucio ^a   Ortiz Lopez, Rocio ^a   Elizondo Gonzalez, Ramiro ^a   Perez Maya, Antonio Ali ^a   Ocampo Candiani, Jorge ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOMYCETOMA; BACTERIAL GENOME; BACTERIUM ISOLATION; EXPERIMENTAL MODEL; GENOME ANALYSIS; IN VITRO STUDY; NOCARDIA BRASILIENSIS; NONHUMAN; NOTE; PRIORITY JOURNAL;

GENOME, BACTERIAL; MOLECULAR SEQUENCE DATA; NOCARDIA;

NOCARDIA BRASILIENSIS;

EID: 84861411625     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00210-12     Document Type: Note

References (14)

1. Almaguer-Chávez JA, et al. 2011. Decrease of virulence for BALB/c mice produced by continuous subculturing of Nocardia brasiliensis. BMC Infect. Dis. 11:290.
2. Brown-Elliott BA, Brown JM, Conville PS, Wallace, RJ, Jr. 2006. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin. Microbiol. Rev. 19:259-282.
3. Frohner IE, Bourgeois C, Yatsyk K, Majer O, Kuchler K. 2009. Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance. Mol. Microbiol. 71:240-252.
4. Gonzalez-Suarez ML, Salinas-Carmona MC, Pérez-Rivera I. 2009. IgM but not IgG monoclonal anti-Nocardia brasiliensis antibodies confer protection against experimental actinomycetoma in BALB/c mice. FEMS Immunol. Med. Microbiol. 57:17-24.
5. Ishikawa J, et al. 2004. The complete genomic sequence of Nocardia farcinica IFM 10152. Proc. Natl. Acad. Sci. U. S. A. 101:14925-14930.
6. Letek M, et al. 2010. The genome of a pathogenic Rhodococcus: cooptive virulence underpinned by key gene acquisitions. PLoS Genet. 6:e1001145.
7. Lopez-Martinez R, et al. 1992. Epidemiology of mycetoma in Mexico: study of 2105 cases. Gac. Med. Mex. 128:477-481. (In Spanish.)
8. Mariat F, Destombes P, Segretain G. 1977. The mycetomas: clinical features, pathology, etiology and epidemiology. Contrib. Microbiol. Immunol. 4:1-39.
9. Salinas-Carmona MC, Rocha-Pizaña MR. 2011. Construction of a Nocardia brasiliensis fluorescent plasmid to study Actinomycetoma pathogenicity. Plasmid 65:25-31.
10. Stackebrandt E, Rainey FA, Ward-Rainey NL. 1997. Proposal for a new hierarchic classification system, Actinobacteria classis nov. Int. J. Syst. Evol. Microbiol. 47:479-491.
11. Vera-Cabrera L, et al. 2010. In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid. Antimicrob. Agents Chemother. 54: 2191-2193.
12. Vera-Cabrera L, Espinoza-González NA, Welsh O, Ocampo-Candiani J, Castro-Garza J. 2009. Activity of novel oxazolidinones against Nocardia brasiliensis growing within THP-1 macrophages. J. Antimicrob. Chemother. 64:1013-1017.
13. Vera-Cabrera L, Johnson WM, Welsh O, Resendiz-Uresti FL, Salinas-Carmona MC. 1999. Distribution of a Nocardia brasiliensis catalase gene fragment in members of the genera Nocardia, Gordona, and Rhodococcus. J. Clin. Microbiol. 37:1971-1976.
14. Welsh O, Vera-Cabrera L, Salinas-Carmona MC. 2007. Mycetoma. Clin. Dermatol. 25:195-202.